GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Research & Development

UPB (Upstream Bio) Research & Development : $37.21 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Upstream Bio Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Upstream Bio's Research & Development for the three months ended in Dec. 2024 was $21.77 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $37.21 Mil.

Upstream Bio Research & Development Historical Data

The historical data trend for Upstream Bio's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Upstream Bio Research & Development Chart

Upstream Bio Annual Data
Trend Dec22 Dec23 Dec24
Research & Development
18.66 31.80 62.97

Upstream Bio Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial 7.79 11.55 - 15.43 21.77

Upstream Bio Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $37.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Upstream Bio  (NAS:UPB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Upstream Bio Research & Development Related Terms

Thank you for viewing the detailed overview of Upstream Bio's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Upstream Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Research & Development
Comparable Companies
URGN DNA NWBO RGNX PGEN EYPT TRML MNMD CGEM OMER VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
890 Winter Street, Suite 200, Waltham, MA, USA, 02451
Website
https://www.upstreambio.com
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.